var title_f2_51_2864="Langerhans histiocytosis CT II";
var content_f2_51_2864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F69891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F69891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic changes in Langerhans cell histiocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 225px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Langerhans cell pulmonary histiocytosis (eosinophilic granuloma) in an adolescent boy characterized by multiple cysts in the upper and lower lobes. The cysts are interspersed throughout the parenchyma and have a slightly thick wall. A posterior right upper lobe nodule and confluent bibasilar patchy lower lobe opacities are also part of the disease process.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2864=[""].join("\n");
var outline_f2_51_2864=null;
var title_f2_51_2865="Therapies hot flashes";
var content_f2_51_2865=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F66833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F66833&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 616px\">",
"   <div class=\"ttl\">",
"    Therapies hot flashes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 596px; height: 390px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hot flash score changes from baseline for a series of eight randomized, placebo-controlled trials, plus a trial in which women were randomized to venlafaxine (75 mg/day) versus a single dose (400 mg) of intramuscular medroxyprogesterone acetate. Six week data shown for the latter trial.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Loprinzi CL, Barton DL, Sloan JA, et al. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause 2008; 15:655. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2865=[""].join("\n");
var outline_f2_51_2865=null;
var title_f2_51_2866="Patient information: Seasonal affective disorder (The Basics)";
var content_f2_51_2866=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?11/57/12179\">",
"         Patient information: Depression (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/6/24675\">",
"         Patient information: Medicines for depression (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?19/41/20116\">",
"         Patient information: Depression in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Seasonal affective disorder (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/seasonal-affective-disorder-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H282385678\">",
"      <span class=\"h1\">",
"       What is seasonal affective disorder?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Seasonal affective disorder (often called &ldquo;SAD&rdquo;) is a form of depression that comes and goes depending on the time of year. There are 2 main types of the disorder:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Fall-onset SAD",
"        </strong>",
"        &ndash; This type of SAD starts in late fall and goes away in the spring and summer. Some people call it &ldquo;winter depression.&rdquo; It is the most common form of SAD.",
"       </li>",
"       <li>",
"        <strong>",
"         Spring-onset SAD",
"        </strong>",
"        &ndash; This type of SAD starts in the spring and goes away in the fall and winter. Spring-onset SAD is much less common than fall-onset SAD.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H282385693\">",
"      <span class=\"h1\">",
"       What are the symptoms of SAD?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms are different depending on which form of SAD a person has.",
"     </p>",
"     <p>",
"      People with fall-onset SAD tend to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Sleep more than usual",
"       </li>",
"       <li>",
"        Have a bigger appetite than usual, especially for sweet or starchy foods, like pastries or rice",
"       </li>",
"       <li>",
"        Gain weight",
"       </li>",
"       <li>",
"        Become cranky or irritable",
"       </li>",
"       <li>",
"        Have trouble with their relationships, especially if they feel like they are being rejected",
"       </li>",
"       <li>",
"        Feel as though their arms and legs are weighted down or filled with lead",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with spring-onset SAD have symptoms that are more like those of typical depression. They tend to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Sleep less than usual",
"       </li>",
"       <li>",
"        Have a smaller appetite",
"       </li>",
"       <li>",
"        Lose weight",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H282385708\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, if you have symptoms of SAD, see a doctor, nurse, or counselor.",
"     </p>",
"     <p>",
"      If you ever feel like you might hurt yourself or someone else, do 1 of these things:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Call your doctor or nurse and tell them it is an emergency",
"       </li>",
"       <li>",
"        Call 9-1-1 for an ambulance",
"       </li>",
"       <li>",
"        Go to the emergency room at your local hospital",
"       </li>",
"       <li>",
"        Contact the National Suicide Prevention Lifeline:",
"       </li>",
"       <li>",
"        1-800-273-8255",
"       </li>",
"       <li>",
"        <a class=\"external\" href=\"file://www.suicidepreventionlifeline.org/\">",
"         www.suicidepreventionlifeline.org",
"        </a>",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H282385723\">",
"      <span class=\"h1\">",
"       How is seasonal affective disorder treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment options include the following:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Light therapy",
"        </strong>",
"        &ndash; Light therapy involves sitting in front of special, bright lamps during the day. This form of therapy can help people with fall-onset SAD. It must be done with help of a doctor or counselor who knows how the therapy works. It&rsquo;s not something people should try to do on their own.",
"       </li>",
"       <li>",
"        <strong>",
"         Medicines called antidepressants",
"        </strong>",
"        &ndash; The same medicines used to treat depression can help people with SAD. It&rsquo;s not clear whether it makes sense to stop and start the medicines every year, based on when SAD usually starts. There are many different antidepressant medicines that doctors can prescribe. The medicines work in different ways and can cause different side effects. If 1 medicine causes problems or does not work, there are often others to try.",
"       </li>",
"       <li>",
"        <strong>",
"         Counseling",
"        </strong>",
"        <strong>",
"         (also called &ldquo;psychotherapy&rdquo;)",
"        </strong>",
"        &ndash; There is no direct proof that counseling specifically helps with SAD. But there is good proof that it helps with depression, so experts think it can also help with SAD.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Experts think that light therapy is often the best treatment to try first for fall-onset SAD, but only if the person is not severely depressed or thinking about suicide. For people who are severely depressed or thinking about suicide, antidepressant medicines might be a better option.",
"     </p>",
"     <p>",
"      You and your doctor, nurse, or counselor can decide which treatment is best for you. Some people do well if they combine different treatments.",
"     </p>",
"     <p>",
"      Whatever treatment you try, keep in mind that it sometimes takes patience to find a treatment that works. In some cases, people who take medicines have to try a few different medicines before they find 1 that works for them. Plus, most treatments take some time before they start working. The key is to work with your doctor, nurse, or counselor, and to keep him or her informed about any problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H282385738\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Some people feel better if they exercise. Even you do not feel like it, try to do something active for at least 30 minutes on most days of the week. There is some proof that the brain makes its own antidepressants during exercise.",
"     </p>",
"     <p>",
"      Also, if you have fall-onset SAD, make sure you get exposed to as much light as possible. Here are some ways you can do that:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Take walks outside during the day, so that you get some sun.",
"       </li>",
"       <li>",
"        In your bedroom, put a lamp on a timer and have it turn on in the early morning, even before the sun comes out.",
"       </li>",
"       <li>",
"        Get a &ldquo;dawn-simulating&rdquo; lamp, which brightens gradually and turns on before the sun comes out.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H282385753\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=see_link\">",
"       Patient information: Depression (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=see_link\">",
"       Patient information: Medicines for depression (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=see_link\">",
"       Patient information: Depression in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?2/51/2866?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83541 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-BE0BA8F269-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2866=[""].join("\n");
var outline_f2_51_2866=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282385678\">",
"      What is seasonal affective disorder?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282385693\">",
"      What are the symptoms of SAD?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282385708\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282385723\">",
"      How is seasonal affective disorder treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282385738\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282385753\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/57/12179?source=related_link\">",
"      Patient information: Depression (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/41/20116?source=related_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/6/24675?source=related_link\">",
"      Patient information: Medicines for depression (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_51_2867="Noncontact map sinus rhythm";
var content_f2_51_2867=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68778&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Noncontact endocardial map during sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The sequence of isopotential maps of the left ventricular endocardium (purple) is modeled to the ventricular chamber dimensions. The location of the multielectrode array is represented by the orange ellipsoid. Surface ECG lead I and selected virtual electrograms from a line following fascicular activation are shown beneath each map. Initial activation (arrow in panel A) occurs in the upper part of the fascicles and then progresses toward the apex (arrow, panel B). At the apex, fascicular activation initiates ventricular activation (white area, panel C).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Peters NS, Jackman WM, Schilling RJ, et al. Circulation 1997; 95:1658.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2867=[""].join("\n");
var outline_f2_51_2867=null;
var title_f2_51_2868="Short axis left main CA";
var content_f2_51_2868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79123%7ECARD%2F54573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79123%7ECARD%2F54573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short axis view of left main coronary artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 203px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The short axis view, with the imaging plane through the aortic root (AO) just above the aortic valve, demonstrates the left main coronary artery (LMCA). Panel B shows the M-mode echocardiogram of the LMCA.",
"    <div class=\"footnotes\">",
"     PV: pulmonary valve.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Two-dimensional transthoracic echocardiogram (2D TTE) from the parasternal short axis view at the level of the coronary arteries",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 260px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The origins of the right (RCA) and left (LCA) coronary arteries can be seen on the short axis precordial view, obtained through the aortic root (Ao) just above the valves; there is a vague \"pinwheel\" relationship of the sweep of the arteries. Additionally, the left atrial appendage (LAA) is seen just inferior to the LCA and the pulmonary valve (PV) just superior.",
"    <div class=\"footnotes\">",
"     LA: left atrium.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2868=[""].join("\n");
var outline_f2_51_2868=null;
var title_f2_51_2869="Skin biopsy NSF Light I";
var content_f2_51_2869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F63319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F63319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Low power light micrograph of a skin biopsy from a patient with nephrogenic systemic fibrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 442px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A low magnification image of a skin biopsy from a patient with nephrogenic systemic fibrosis shows subcutaneous septa that are widely expanded by collagen deposits (arrow). The asterisk highlights an area of normal septal thickness, and S indicates the skin surface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from: Shawn E Cowper, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2869=[""].join("\n");
var outline_f2_51_2869=null;
var title_f2_51_2870="Moxifloxacin (systemic): Patient drug information";
var content_f2_51_2870=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Moxifloxacin (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/29/21976?source=see_link\">",
"     see \"Moxifloxacin (systemic): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9347899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Avelox&reg;;",
"     </li>",
"     <li>",
"      Avelox&reg; ABC Pack;",
"     </li>",
"     <li>",
"      Avelox&reg; I.V.",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9347900\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Avelox&reg;;",
"     </li>",
"     <li>",
"      Avelox&reg; I.V.",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700791",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of tendons getting irritated and tearing. The chance is greater in people over the age of 60; heart, kidney, or lung transplant patients; or people taking steroid drugs. Call your doctor right away if you have pain in the back of the ankle or joint pain or swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700299",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you have myasthenia gravis. Very bad effects may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to moxifloxacin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703760",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had tendons get irritated or torn when taking this drug or an alike drug in the past.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703791",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697757",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care in children younger than 18 years of age. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low potassium levels or if you are taking a water pill, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids, didanosine, iron, multivitamins, or sucralfate within 8 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698369",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tendons may rarely get irritated and tear.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024275\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698993",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pain in back of the ankle.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698967",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint pain or swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024277\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12263 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-5CF79EDF2C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2870=[""].join("\n");
var outline_f2_51_2870=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9347899\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9347900\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024266\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024268\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024267\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024272\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024273\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024275\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024270\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024271\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024276\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024277\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?18/10/18595?source=related_link\">",
"      Moxifloxacin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?9/45/9940?source=related_link\">",
"      Moxifloxacin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/50/5924?source=related_link\">",
"      Moxifloxacin (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/29/21976?source=related_link\">",
"      Moxifloxacin (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_51_2871="Cumulative incidence of hepatocellular carcinoma";
var content_f2_51_2871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F83282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F83282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 636px\">",
"   <div class=\"ttl\">",
"    Cumulative incidence of hepatocellular carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 616px; height: 973px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cumulative incidence of hepatocellular carcinoma by:",
"    <br/>",
"    (A) Group of long-term HBV DNA change.",
"    <br/>",
"    (B) Long-term pattern of ALT.",
"    <br/>",
"    Both P values for log-rank tests were &lt;0.001.",
"    <div class=\"footnotes\">",
"     * Data were not available for 326 participants because of &lt;2 measurements of ALT level.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      ALT level &ge;45 U/L in &ge;50 percent of sequential ALT measurements.",
"      <br>",
"       &Delta; At least one ALT level &ge;45 U/L but &lt;50 percent of sequential ALT measurements &ge;45 U/L.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        All sequential ALT measurements &lt;45 U/L and at least one ALT level &gt;30 U/L.",
"        <br>",
"         &sect; All sequential ALT measurements &le;30 U/L.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Chen CF, Lee WC, Yang HI, et al. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology 2011; 141:1240. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2871=[""].join("\n");
var outline_f2_51_2871=null;
var title_f2_51_2872="Risk prediction models for breast cancer screening";
var content_f2_51_2872=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Risk prediction models for breast cancer screening",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/51/2872/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/51/2872/contributors\">",
"     Suzanne W Fletcher, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/51/2872/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/51/2872/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/51/2872/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/51/2872/contributors\">",
"     H Nancy Sokol, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/51/2872/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is growing interest in trying to stratify women into groups of different levels of risk for developing breast cancer. Several breast cancer risk prediction tools have been developed that combine major risks factors. The purpose of the models is to better stratify women into risk categories that can be used to tailor screening decisions and strategies for clinical management of the individual patient [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Breast cancer risk assessment tools are helpful in determining the risk group a patient is in. However, their accuracy for individual women is only modest, partly because not all important risks have been identified and partly because accurate risk stratification requires strong risk factors and most risk factors for breast cancer are relatively weak and common in the population [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/2\">",
"     2",
"    </a>",
"    ]. Clinical judgment must be factored in to the application of model-based predictions to determine an individual&rsquo;s appropriateness for genetic testing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    preventive treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss clinical implications of breast cancer risk prediction and provide an overview of tools that the primary care clinician can use to assess breast cancer risk for screening decisions. A more detailed discussion of risk assessment tools for genetic counseling and testing by oncologists, as well as discussions of screening for breast cancer, risk factors for breast cancer, and management options for women with a genetic predisposition to breast and ovarian cancer, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=see_link\">",
"     \"Screening for breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28954?source=see_link\">",
"     \"Factors that modify breast cancer risk in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17418?source=see_link\">",
"     \"Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32249?source=see_link\">",
"     \"Genetic testing for hereditary breast and ovarian cancer syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/60/5064?source=see_link\">",
"     \"Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CONCEPTS IN RISK DETERMINATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Time frame of risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;On average, 13 percent of women develop breast cancer by the age of 90. For clinical decisions about screening and for better understanding of risk by patients, a shorter time frame (usually five to ten years) is more helpful. The percent of white women at a given age who will develop breast cancer over a five-year period and until age 90 is shown in a table (",
"    <a class=\"graphic graphic_table graphicRef52691 \" href=\"UTD.htm?21/33/22043\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Meaning of \"average\" risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Average five-year risks for breast cancer increase with age (",
"    <a class=\"graphic graphic_table graphicRef52691 \" href=\"UTD.htm?21/33/22043\">",
"     table 1",
"    </a>",
"    ), and thus the risk threshold that determines if a woman is at \"average risk\" is age-dependent. As an example, a woman with a 2.2 percent chance of developing breast cancer in the next five years would be at average risk if she were 70 years old, but at high risk if she were 40 (when the average five-year risk of developing breast cancer is 0.6 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Combining multiple risks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many factors influence risk for breast cancer (",
"    <a class=\"graphic graphic_table graphicRef64508 \" href=\"UTD.htm?15/52/16205\">",
"     table 2",
"    </a>",
"    ). With the exception of certain genetic mutations, the relative risk associated with a single factor is too small to be useful by itself for stratifying women of a given age into risk groups; other risk factors may be important influences. As an example, one study found that the five-year risk of developing breast cancer in 40- to 44-year-old women with extremely dense breasts on mammography varied from 0.8 percent (similar to the risk of an average woman) to 2.2 percent, depending on her history of breast biopsy and family history of breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cost-effectiveness of mammography according to various combinations of frequency of mammography, patient age, breast density, family history of breast cancer among first degree relatives, and personal history of breast biopsy was evaluated in another study [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/5\">",
"     5",
"    </a>",
"    ]. Adding information about risk factors other than age identified subsets of women for whom mammography screening is cost-effective either biennially or every three to four years (",
"    <a class=\"graphic graphic_figure graphicRef67061 \" href=\"UTD.htm?8/33/8725\">",
"     figure 1",
"    </a>",
"    ). As an example, for women ages 40 to 49, biennial mammography was cost effective (using a threshold of $50,000 per QALY gained) for women with radiographically dense breasts (BI-RADS breast density category 3 or 4) and with either a family history of breast cancer or a previous breast biopsy. If the threshold was raised to $100,000 per QALY gained, biennial mammography was cost effective for women with either dense breasts or both family history and a previous breast biopsy. Biennial mammography was cost effective for other combinations of breast density, family history of breast cancer, and history of breast biopsy as well. This model should be further validated using data derived from other patient populations.",
"   </p>",
"   <p>",
"    Risk assessment prediction tools have been developed to take into account influences of concurrent multiple risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Assessing model validity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usefulness or accuracy of a prediction model is commonly assessed by two determinations: calibration and discrimination. Sensitivity and specificity can also be calculated.",
"   </p>",
"   <p>",
"    Calibration involves measuring the performance of a tool at the population level in a large group of women. Calibration determines how accurately a model predicts the observed rate of cancer and is measured by comparing the number of women in a group estimated by the prediction model to develop breast cancer (E) with the number who are actually diagnosed with breast cancer (observed, O). If calibration of the model is good, the ratio of",
"    <span class=\"nowrap\">",
"     E/O",
"    </span>",
"    will be close to 1.00.",
"   </p>",
"   <p>",
"    Discrimination assesses performance at the individual level and involves determining how well the model stratifies women into those who do and do not develop breast cancer over a five-year period. A model that discriminates well at the individual woman level should consistently predict a higher risk for women ultimately diagnosed with the disease, compared to the risk for women who do not develop the disease.",
"   </p>",
"   <p>",
"    Concordance (or c-statistic) for breast cancer is the proportion of randomly selected pairs of women, with and without a breast cancer diagnosis, in which the woman developing breast cancer has a higher calculated risk than the woman without disease. The resulting calculation can range from a c-statistic of 0.50 (breast cancer risk is higher for women who developed breast cancer in 50 percent of pairs, equivalent to a coin toss) to 1.0 (perfect discrimination) (",
"    <a class=\"graphic graphic_figure graphicRef76746 \" href=\"UTD.htm?38/6/39022\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In general, risk prediction tools achieve better calibration (accurately predicting the number of women in a risk group that will develop breast cancer) than discrimination (predicting which individual women in the group will develop breast cancer). Most risk factors for breast cancer are modest; one commentary calculated that for a risk factor (or combination) to detect even half of the individuals destined to develop disease, with a 5 percent false-positive rate, a relative risk of about 200 is required [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TOOLS TO PREDICT BREAST CANCER RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple breast cancer risk models have been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/7-18\">",
"     7-18",
"    </a>",
"    ]. All models listed below calculate breast cancer risk, and some also calculate risk of BRCA1 and BRCA2. Some calculate both five-year and lifetime risks, although lifetime duration is not the same in all models. Finally, the type and number of variables differ, some concentrating more on family history and others including personal variables such as history of breast biopsies, parity, and mammographic density. The listed models are all available online; other models have been developed but are not readily available to practicing clinicians.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Breast Cancer Risk Assessment Tool (Gail model)",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most widely available tool to calculate breast cancer risk is the Breast Cancer Risk Assessment Tool (BCRAT), sometimes called the Gail model after Dr. Mitchell Gail, its developer at the National Cancer Institute [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. The tool is based upon data from the Breast Cancer Detection Demonstration Project (BCDDP) and the Care Trial [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/9\">",
"     9",
"    </a>",
"    ]. It allows calculation of a woman's individual risk of developing breast cancer over the next five years and until age 90, based on the following data for the individual:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Current age",
"     </li>",
"     <li>",
"      Age of menarche",
"     </li>",
"     <li>",
"      Age of first live birth",
"     </li>",
"     <li>",
"      Number of first degree relatives with breast cancer",
"     </li>",
"     <li>",
"      Number of previous breast biopsies",
"     </li>",
"     <li>",
"      Whether any breast biopsy has shown atypical hyperplasia",
"     </li>",
"     <li>",
"      Race",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An individual's risk is compared with that of a woman the same age and with average risk factors, although no confidence intervals are used around the estimates. The tool can be accessed online at",
"    <a class=\"external\" href=\"file://www.cancer.gov/bcrisktool/\">",
"     www.cancer.gov/bcrisktool/",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The Gail Model has been developed using data primarily from studies of white and black women. Risk estimates for races or ethnicities other than Caucasian and black may not be as accurate, either because no studies have been conducted or less data have been analyzed.",
"   </p>",
"   <p>",
"    The BCRAT is intended for women without a strong family history suggesting inherited breast cancer. It is not applicable to women with more than two first degree relatives with breast cancer and does not consider more distant relatives, the age at which relatives developed breast cancer, or a family history of ovarian cancer. It is not useful for women with a strong family history of breast cancer on the paternal side.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Accuracy of Gail model",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several groups have evaluated the Gail model [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4,10,19\">",
"     4,10,19",
"    </a>",
"    ]. The model works well at the population level, with calibration calculated at 0.94 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4\">",
"     4",
"    </a>",
"    ], 1.01 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/10\">",
"     10",
"    </a>",
"    ], and 1.03 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk prediction models are sensitive to underlying breast cancer incidence trends in the populations. The original Gail model was based on breast cancer data collected between 1983 and 1987. Incidence rates of breast cancer in the United States increased during the 1990s and have since decreased. Validation studies in women groups during the 1990s found that the Gail model under-predicted the number of invasive breast cancers, whereas an updated model using appropriate incidence was better calibrated [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/20\">",
"     20",
"    </a>",
"    ]. A strength of the Gail model is that it is periodically updated to incorporate results of new studies.",
"   </p>",
"   <p>",
"    Although the Gail model works well at the population level, it does not discriminate well at the level of individual women, with the c-statistic calculated in different studies ranging from 0.58 to 0.63 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4,10,19\">",
"     4,10,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A figure illustrates the limited ability of the Gail model to stratify women into groups who will and will not develop breast cancer (",
"    <a class=\"graphic graphic_figure graphicRef54619 \" href=\"UTD.htm?18/45/19166\">",
"     figure 3",
"    </a>",
"    ). This data is derived from a study of the Gail model applied to 82,109 white women ages 45 to 74 [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/19\">",
"     19",
"    </a>",
"    ]. The calculated risks of women who did and did not develop breast cancer overlap substantially, and there is no place along the x-axis of risk that separates women into groups who did and did not develop breast cancer.",
"   </p>",
"   <p>",
"    Sensitivity and specificity, related to discrimination, are especially clinically relevant. The sensitivity of the Gail model (identifying women who will develop breast cancer) has been calculated at 44 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/19\">",
"     19",
"    </a>",
"    ] and 28 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4\">",
"     4",
"    </a>",
"    ] using a five-year risk of 1.67 percent as the cut point between \"high\" and \"low\" risk. This cut point was derived from the large breast cancer prevention trial in which the cut point for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    prophylaxis was a five-year risk of 1.66 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/21\">",
"     21",
"    </a>",
"    ]. The specificity of the Gail model, reported in studies as 66 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/19\">",
"     19",
"    </a>",
"    ] or 88 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4\">",
"     4",
"    </a>",
"    ], is also low. In one study, the positive predictive value was 2.30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4\">",
"     4",
"    </a>",
"    ]. When comparing these test performances to those usually found for good diagnostic tests, the limited discrimination ability of the Gail model is clear.",
"   </p>",
"   <p>",
"    Efforts to improve on the Gail model have mainly centered on adding mammographic breast density to other risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/4,10,11\">",
"     4,10,11",
"    </a>",
"    ]. Calculated c-statistics increased modestly, to between 0.62 and 0.66.",
"   </p>",
"   <p>",
"    In summary, the NCI's BCRAT is readily available to clinicians and patients, has been extensively evaluated, and works well at a population level. When an individual woman and her clinician use it, they should understand that the results are only approximate. Also, the model is less useful for the rarer women with strong family history of breast",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ovarian cancer because it does not incorporate several important details.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Models emphasizing family risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk prediction models have been developed for patients with a history of multiple family members with breast cancer, or a family member with ovarian cancer. These models not only assess the risk of breast cancer but also the risk of carrying a deleterious BRCA1 or BRCA2 gene. These estimates are then used to select women for genetic testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32249?source=see_link\">",
"     \"Genetic testing for hereditary breast and ovarian cancer syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The validity of these models should be assessed in the same way as the BCRAT has been; information about calibration, discrimination, sensitivity, and specificity is available for some (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Assessing model validity'",
"      </a>",
"      above). Several models with software available online are discussed below.",
"      <br/>",
"      <br/>",
"      BRCAPRO was developed by investigators at the University of Texas Southwestern Medical Center at Dallas and Duke University (available for downloading at",
"      <a class=\"external\" href=\"file://www4.utsouthwestern.edu/breasthealth/cagene/\">",
"       www4.utsouthwestern.edu/breasthealth/cagene/",
"      </a>",
"      ). BRCAPRO incorporates six predictive models for inherited or familial breast cancer: the Claus family history model [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/12\">",
"       12",
"      </a>",
"      ], the Couch model [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/13\">",
"       13",
"      </a>",
"      ], the Shattuck-Eidens model [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/14\">",
"       14",
"      </a>",
"      ], the Frank model [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/15\">",
"       15",
"      </a>",
"      ], and a Bayesian probability model developed by the investigators [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/16,22\">",
"       16,22",
"      </a>",
"      ]. The resulting program can be used to construct a family history tree that considers as much information as available to calculate the woman's chance of developing breast (or ovarian) cancer and the probability of carrying a deleterious BRCA1 or BRCA2 gene.",
"      <br/>",
"      <br/>",
"      The sensitivity of the BRCAPRO computer model for identifying mutation carriers was similar to that of experienced risk counselors in one report [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/23\">",
"       23",
"      </a>",
"      ]. The BRCAPRO program performs as well in African American and Hispanic families as it does in Caucasian and Jewish populations [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/22,24,25\">",
"       22,24,25",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      When the validity of BRCAPRO was assessed in one study, investigators found a c-statistic of 0.76 (95% CI 0.71-0.81) for distinguishing women who develop breast cancer from those who did not and 0.82 (95% CI 0.81-0.84) for distinguishing individuals testing positive for BRCA1 or BRCA2 from women negative for both genes [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/26\">",
"       26",
"      </a>",
"      ]. The BRCAPRO model performed better than other assessed models in most subgroups of women. Another study found that adding pathological features of any breast cancer diagnosed in the family (grade, estrogen-receptor status, and progesterone-receptor status) to the BRCAPRO calculation improved the c-statistic for BRCA1 gene mutation from 0.84 to 0.92 [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Claus model is based on family history and takes into account both maternal and paternal family history of breast cancer, including the age at onset, and calculates risk according to the age of the woman [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/12\">",
"       12",
"      </a>",
"      ]. A study comparing the Claus model to several others found its calibration and discrimination was similar to several others but inferior to the Tyrer-Cuzick model [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Tyrer-Cuzik model was designed to predict 10-year breast cancer development [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/17\">",
"       17",
"      </a>",
"      ]. Like BRCAPRO, it includes family history of breast and ovarian cancer, but also includes non-genetic risk factors such as age of menarche and history of atypical hyperplasia. It was developed in the early 2000s and is used for breast cancer risk assessment in the UK International Breast Cancer Intervention Study (IBIS) trial for breast cancer prevention. The model is available by contacting IBIS at ibis@cancer.org.uk. 2004 software downloads are available at",
"      <a class=\"external\" href=\"file://www.ems-trials.org/riskevaluator/\">",
"       www.ems-trials.org/riskevaluator/",
"      </a>",
"      , but a statement specifies they are for research purposes only.",
"      <br/>",
"      <br/>",
"      Evaluation of the model in a family history evaluation and screening program found that calibration of the model was 1.08 and discrimination using ROC curves was 0.762, better than the other models tested [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/28\">",
"       28",
"      </a>",
"      ]. However, at the Mayo Clinic, in a cohort of 331 women with atypical hyperplasia followed for 10 years, the Tyrer-Cuzick model's calculated observed-to-predicted ratio (calibration) was poor, 0.53 (95% CI 0.37 to 0.75), and the concordance statistic was 0.54 (95% CI 0.42 to 0.65), little better than chance [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/29\">",
"       29",
"      </a>",
"      ]. The authors concluded they could not recommend the use of the Tyrer-Cuzick model to predict 10-year breast cancer risk in women with atypical hyperplasia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because different models include different features of family history, the resulting risk predictions may differ. Much of the data used to construct these models are from women with existing cancer; their applicability to asymptomatic, cancer-free women in the general population is unknown. One study found that all the models tested had high false-positive and false-negative rates when used in groups of women not at high risk [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Furthermore, most genetic risk models are largely based on family history. Their applicability to individuals with a limited family structure (ie, a maternal or paternal lineage with fewer than two female relatives, first- or second-degree, over age 45) has been questioned. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32249?source=see_link&amp;anchor=H1971688#H1971688\">",
"     \"Genetic testing for hereditary breast and ovarian cancer syndrome\", section on 'Patients with limited family structure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Incorporation of non-BRCA genetic data",
"    </span>",
"    &nbsp;&mdash;&nbsp;BRCA1 and BRCA2 are the currently identifiable genes that account for the majority of inherited breast cancers. These genes are inherited in an autosomal dominant fashion and have high penetrance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32249?source=see_link\">",
"     \"Genetic testing for hereditary breast and ovarian cancer syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple other genetic variants have been associated with increased risk for breast cancer, but individually confer far lower risk than BRCA1 or BRCA1. A study that compared classification of risk using the Gail model or the Gail model plus 10 common genetic susceptibility variants, other than those associated with BRCA1 or BRCA2, found that inclusion of the genetic factors only modestly improved performance of the risk model for breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/30\">",
"     30",
"    </a>",
"    ]. Another study evaluated the inclusion of a &ldquo;SNP risk score,&rdquo; based on seven SNPs associated with risk for breast cancer in white non-Hispanic women, in a risk model combined with the Gail model [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/31\">",
"     31",
"    </a>",
"    ]. The combined risk model modestly improved risk prediction performance, compared to the Gail model alone, with the greatest impact for women at intermediate risk.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Guidelines based on ethnicity and family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk assessment models can be difficult to obtain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cumbersome to use, particularly for primary care clinicians who must decide which patients to refer for genetic testing. Several simpler criteria sets of indications for genetic counseling, based upon an individual's family history, have been developed. The validity of these tools has not been assessed. Examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Guidelines are available from the US Preventive Services Task Force (USPSTF) to identify unaffected women at high risk for BRCA mutations. The specific family history patterns that warrant genetic counseling and consideration for genetic testing are presented in a table (",
"      <a class=\"graphic graphic_table graphicRef57434 \" href=\"UTD.htm?27/17/27931\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Similar criteria for identifying appropriate women for genetic counseling and possible testing are available from the National comprehensive Cancer Network (NCCN) (",
"      <a class=\"graphic graphic_table graphicRef56222 \" href=\"UTD.htm?21/58/22445\">",
"       table 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Three tools have been developed specifically for primary care clinicians to assess risk and guide referral: the Family History Risk Assessment Tool [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/34\">",
"       34",
"      </a>",
"      ], the Manchester scoring system [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/35\">",
"       35",
"      </a>",
"      ], and the Risk Assessment in Genetics tool (RAG) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2872/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CLINICAL USE OF RISK PREDICTION MODELS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breast cancer risk prediction tools, especially the Gail model, express risk in clinically meaningful ways, with percentages and a five-year time period as well as lifetime risk.",
"   </p>",
"   <p>",
"    It may help a woman comprehend individual numeric risks for breast cancer to know that most women, even in high risk groups, do not develop breast cancer, especially over a five-year period. It is also important that a woman understands that the tools work best for a group of women with clinical attributes similar to hers and that individual estimates are subject to error because of relatively low sensitivity and specificity.",
"   </p>",
"   <p>",
"    When a tool such as the BCRAT suggests that a woman is a member of a group of women with an elevated risk of breast cancer, or if there is a strong family history of breast",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ovarian cancer, referral for more detailed risk analysis is appropriate. This risk analysis would incorporate risk tools emphasizing family history, to determine whether counseling regarding genetic testing is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/59/19379?source=see_link\">",
"       \"Patient information: Breast cancer screening (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/40/36481?source=see_link\">",
"       \"Patient information: Breast cancer screening (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Determining whether a patient is in an increased risk group for breast cancer can be helpful in optimizing strategies for screening and clinical management, but does not necessarily accurately predict an individual's risk for developing breast cancer over the specified timeframe. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since the risk of developing breast cancer increases with age, the risk threshold for determining \"average risk\" also increases with age. Aside from certain genetic mutations, no other single risk factor is strong enough alone and assessment tools take into account combinations of risk factors. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Concepts in risk determination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk models are validated by calibration (how accurately the model predicts the observed rate of cancer in a group of women) and by discrimination (how well the model stratifies women into those who will and will not develop breast cancer). The c-statistic measures calibration; a value of 0.5 indicates the model performs no better than chance. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Assessing model validity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Breast Cancer Risk Assessment Tool (BRCAT or Gail model), available at",
"      <a class=\"external\" href=\"file://www.cancer.gov/bcrisktool/\">",
"       www.cancer.gov/bcrisktool/",
"      </a>",
"      , assesses an individual's risk of developing breast cancer over five years; it is not intended for women with a strong family history of breast cancer. The Gail model, however, has a relatively low positive predictive value of breast cancer for an individual patient. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Breast Cancer Risk Assessment Tool (Gail model)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several models incorporating family history have been developed, to assess both risk of breast cancer and risk of carrying a deleterious BRCA1 or BRCA2 gene. The BRCAPRO is one such model and performs relatively well in women with a strong family history of breast cancer. The model also calculates the probability of possessing a BRCA1 or BRCA2 mutation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Models emphasizing family risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several groups have developed simpler criteria sets or models to help determine need for referral for genetic counseling. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Guidelines based on ethnicity and family history'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In using these tools in clinical practice, it is important that a patient understand that model predictions have significant error when applied to individuals and that most women, even in high-risk groups, do not develop breast cancer. Referral for more detailed risk analysis is appropriate for women identified as being in a group of women with an elevated risk of breast cancer and those with a strong family history of breast",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ovarian cancer. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Clinical use of risk prediction models'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Institute of Medicine and National Research Council. Saving women's lives: Strategies for improving breast cancer detection and diagnosis. National Academy Press; Washington, DC 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/2\">",
"      Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ 1999; 319:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/3\">",
"      Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010; 102:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/4\">",
"      Tice JA, Cummings SR, Smith-Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008; 148:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/5\">",
"      Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011; 155:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/6\">",
"      Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009; 101:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/7\">",
"      Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/8\">",
"      Benichou J, Gail MH, Mulvihill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/9\">",
"      Gail MH, Costantino JP, Pee D, et al. Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 2007; 99:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/10\">",
"      Barlow WE, White E, Ballard-Barbash R, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006; 98:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/11\">",
"      Chen J, Pee D, Ayyagari R, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006; 98:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/12\">",
"      Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994; 73:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/13\">",
"      Couch FJ, DeShano ML, Blackwood MA, et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/14\">",
"      Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 1995; 273:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/15\">",
"      Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 1998; 16:2417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/16\">",
"      Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998; 62:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/17\">",
"      Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/18\">",
"      Jacobi CE, de Bock GH, Siegerink B, van Asperen CJ. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Breast Cancer Res Treat 2009; 115:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/19\">",
"      Rockhill B, Spiegelman D, Byrne C, et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001; 93:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/20\">",
"      Schonfeld SJ, Pee D, Greenlee RT, et al. Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol 2010; 28:2411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/21\">",
"      Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/22\">",
"      Berry DA, Iversen ES Jr, Gudbjartsson DF, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002; 20:2701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/23\">",
"      Euhus DM, Smith KC, Robinson L, et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 2002; 94:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/24\">",
"      Nanda R, Schumm LP, Cummings S, et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 2005; 294:1925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/25\">",
"      Huo D, Senie RT, Daly M, et al. Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. J Clin Oncol 2009; 27:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/26\">",
"      Parmigiani G, Chen S, Iversen ES Jr, et al. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 2007; 147:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/27\">",
"      James PA, Doherty R, Harris M, et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 2006; 24:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/28\">",
"      Amir E, Evans DG, Shenton A, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003; 40:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/29\">",
"      Boughey JC, Hartmann LC, Anderson SS, et al. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol 2010; 28:3591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/30\">",
"      Wacholder S, Hartge P, Prentice R, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010; 362:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/31\">",
"      Mealiffe ME, Stokowski RP, Rhees BK, et al. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 2010; 102:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/32\">",
"      U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med 2005; 143:355.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network guidelines available online at www.nccn.org (Accessed on May 17, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/34\">",
"      Gilpin CA, Carson N, Hunter AG. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet 2000; 58:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/35\">",
"      Evans DG, Eccles DM, Rahman N, et al. A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet 2004; 41:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2872/abstract/36\">",
"      Emery J, Walton R, Coulson A, et al. Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients. BMJ 1999; 319:32.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7560 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-BE0BA8F269-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2872=[""].join("\n");
var outline_f2_51_2872=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CONCEPTS IN RISK DETERMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Time frame of risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Meaning of \"average\" risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Combining multiple risks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Assessing model validity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TOOLS TO PREDICT BREAST CANCER RISK",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Breast Cancer Risk Assessment Tool (Gail model)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Accuracy of Gail model",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Models emphasizing family risk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Incorporation of non-BRCA genetic data",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Guidelines based on ethnicity and family history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CLINICAL USE OF RISK PREDICTION MODELS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/7560\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7560|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/33/8725\" title=\"figure 1\">",
"      Cost-effective mammography screening strategies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/6/39022\" title=\"figure 2\">",
"      Risk model accuracy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/45/19166\" title=\"figure 3\">",
"      Gail model accuracy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7560|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/33/22043\" title=\"table 1\">",
"      Risk devel BC white women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/52/16205\" title=\"table 2\">",
"      Risk factors breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/17/27931\" title=\"table 3\">",
"      BRCA testing USPSTF guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/58/22445\" title=\"table 4\">",
"      BRCA testing NCCN criteria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28954?source=related_link\">",
"      Factors that modify breast cancer risk in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/60/5064?source=related_link\">",
"      Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/31/32249?source=related_link\">",
"      Genetic testing for hereditary breast and ovarian cancer syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17418?source=related_link\">",
"      Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/40/36481?source=related_link\">",
"      Patient information: Breast cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/59/19379?source=related_link\">",
"      Patient information: Breast cancer screening (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/49/41754?source=related_link\">",
"      Screening for breast cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_51_2873="Tinea pedis moccasin";
var content_f2_51_2873=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68583%7EPC%2F67076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68583%7EPC%2F67076&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea pedis, moccasin distribution",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Diffuse scale on the plantar surface is present in this patient with tinea pedis in the \"moccasin\" distribution.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tinea pedis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-demarcated area of scale and erythema is present in this patient with spread of interdigital tinea pedis to the dorsal foot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Denise W. Metry, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2873=[""].join("\n");
var outline_f2_51_2873=null;
var title_f2_51_2874="Bipolar disorder in women: Preconception and prenatal maintenance pharmacotherapy";
var content_f2_51_2874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bipolar disorder in women: Preconception and prenatal maintenance pharmacotherapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/51/2874/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/51/2874/contributors\">",
"     Victoria Hendrick, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/51/2874/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/51/2874/contributors\">",
"     Paul Keck, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/51/2874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/51/2874/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/51/2874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H581521\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Euthymic bipolar patients often receive maintenance pharmacotherapy prior to conception and during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Onset of bipolar disorder in women typically occurs during childbearing years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/3\">",
"     3",
"    </a>",
"    ], and most patients are at risk for recurrent mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews preconception and prenatal maintenance pharmacotherapy for bipolar patients. Indications for maintenance pharmacotherapy during pregnancy, the teratogenic risks of medications used for bipolar disorder, preconception counseling and care for bipolar disorder, and the general maintenance treatment of bipolar disorder are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25638?source=see_link\">",
"       \"Bipolar disorder in women: Indications for preconception and prenatal maintenance pharmacotherapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link\">",
"       \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40329?source=see_link\">",
"       \"Bipolar disorder in women: Contraception and preconception assessment and counseling\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link\">",
"       \"Bipolar disorder in adults: Maintenance treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H581793\">",
"    <span class=\"h1\">",
"     DEFINITION OF BIPOLAR DISORDER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar disorder is a mood disorder that is characterized by episodes of mania (",
"    <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"     table 1",
"    </a>",
"    ), hypomania (",
"    <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"     table 2",
"    </a>",
"    ), and major depression (",
"    <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"     table 3",
"    </a>",
"    ), as well as mixed episodes (major depression concurrent with mania) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/4\">",
"     4",
"    </a>",
"    ]. The subtypes of bipolar disorder include bipolar I and bipolar II. Patients with bipolar I disorder experience manic and mixed episodes, and nearly always experience major depressive and hypomanic episodes. Bipolar II disorder is marked by at least one hypomanic episode, at least one major depressive episode, and the absence of manic and mixed episodes. Additional information about the clinical features and diagnosis of bipolar disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H4#H4\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Clinical manifestations and diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4469121\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H259024962\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preconception and prenatal maintenance treatment for bipolar patients is usually provided by perinatal or general psychiatrists in collaboration with obstetricians and primary care clinicians [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/5-8\">",
"     5-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After considering medical advice about the risks of fetal exposure to medications and the risks of avoiding preconception and prenatal maintenance pharmacotherapy, bipolar patients can choose to [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maintain existing pharmacotherapy throughout conception, the pregnancy, and birth",
"     </li>",
"     <li>",
"      Switch medications before they try to conceive to avoid drugs with a greater risk of teratogenicity",
"     </li>",
"     <li>",
"      Discontinue pharmacotherapy prior to conception and restart medications during the second or third trimester (when organogenesis is completed).",
"     </li>",
"     <li>",
"      Discontinue pharmacotherapy prior to conception and remain medication-free throughout conception, the pregnancy, and delivery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For bipolar patients who plan to or do become pregnant, we suggest maintenance pharmacotherapy to prevent mood episodes, based upon prospective observational studies that found untreated pregnant patients were at increased risk of recurrent mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/2,10\">",
"     2,10",
"    </a>",
"    ], as well as our clinical experience and that of several authorities [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,11-14\">",
"     1,11-14",
"    </a>",
"    ]. However, for patients with a mild lifetime course of illness, it is reasonable to try to avoid pharmacotherapy during pregnancy. Indications for preconception and prenatal maintenance pharmacotherapy, risks of avoiding maintenance pharmacotherapy, and specific drugs suggested as preconception and prenatal maintenance treatment are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25638?source=see_link\">",
"     \"Bipolar disorder in women: Indications for preconception and prenatal maintenance pharmacotherapy\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H259025003\">",
"     'Risks of avoiding pharmacotherapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H51186202\">",
"     'Specific drugs'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In prescribing preconception and prenatal maintenance pharmacotherapy, clinicians should attempt to use [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,5,15\">",
"     1,5,15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Drugs with fewer known teratogenic effects",
"     </li>",
"     <li>",
"      Monotherapy",
"     </li>",
"     <li>",
"      Doses at the low end of the therapeutic range",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For euthymic bipolar patients who are receiving preconception or prenatal maintenance treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , a second-generation antipsychotic, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , we suggest continuing the same drug [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. For patients who are currently treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , we suggest switching treatment to avoid the teratogenic effects of these two antiepileptics [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/11,17\">",
"     11,17",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H259027145\">",
"     'Switching from valproate or carbamazepine to less teratogenic drugs'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=see_link&amp;anchor=H4#H4\">",
"     \"Risks associated with epilepsy and pregnancy\", section on 'Effect of antiepileptic drugs on the fetus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Female bipolar patients who want to conceive and continue maintenance treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    can consider in vitro fertilization and use of a gestational carrier [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15015?source=see_link\">",
"     \"Surrogate pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Medication doses generally need to be increased over the course of pregnancy, especially in the second and third trimesters, to prevent decreases in serum concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. This is because pregnancy causes physiologic changes that alter pharmacokinetics (eg, increased extracellular fluid volume and body fat increase the volume of distribution, increased activity of hepatic enzymes increases metabolism, and increased renal blood flow and glomerular filtration rate increase renal elimination).",
"   </p>",
"   <p>",
"    Recurrent bipolar mood episodes may occur despite preconception or prenatal maintenance pharmacotherapy because of problems with adherence [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/9\">",
"     9",
"    </a>",
"    ]. Suggestions for improving adherence are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H1205113#H1205113\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Adherence'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1046366\">",
"    <span class=\"h2\">",
"     Risk of adverse pregnancy and birth outcomes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of adverse pregnancy and birth outcomes in women with bipolar disorder who receive pharmacotherapy and women with bipolar disorder who are not treated with pharmacotherapy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40329?source=see_link&amp;anchor=H6188640#H6188640\">",
"     \"Bipolar disorder in women: Contraception and preconception assessment and counseling\", section on 'Risk of adverse pregnancy and birth outcomes'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55179445\">",
"    <span class=\"h2\">",
"     Teratogenic and postnatal risks of pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the first trimester, the risk of teratogenesis decreases and it is safer to prescribe drug combinations and higher doses. The teratogenic and postnatal risks of medications commonly used to treat bipolar disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H259025003\">",
"    <span class=\"h2\">",
"     Risks of avoiding pharmacotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For bipolar patients who are receiving preconception or prenatal maintenance pharmacotherapy, discontinuing treatment includes the following risks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/2,10,13,17,22\">",
"     2,10,13,17,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is not known if maintenance drugs that are discontinued provide the same level of prophylactic efficacy after they are restarted.",
"     </li>",
"     <li>",
"      Stopping treatment may increase the risk of recurrent mood episodes, particularly if medications are discontinued abruptly (eg, in less than two weeks). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40329?source=see_link&amp;anchor=H317273#H317273\">",
"       \"Bipolar disorder in women: Contraception and preconception assessment and counseling\", section on 'Relapse after discontinuing pharmacotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treating recurrent episodes during pregnancy may be difficult and expose the fetus to more medications at higher doses compared with pharmacologic maintenance of euthymia.",
"     </li>",
"     <li>",
"      Postpartum mood episodes may occur more frequently in patients who are not treated with maintenance pharmacotherapy during pregnancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H259027145\">",
"    <span class=\"h2\">",
"     Switching from valproate or carbamazepine to less teratogenic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;For bipolar patients who plan to become pregnant, are treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , and are clinically stable (eg, euthymic for at least six months), we suggest that clinicians attempt to switch maintenance treatment to other drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/11,23\">",
"     11,23",
"    </a>",
"    ]. Valproate and carbamazepine are generally regarded as teratogens, primarily based upon observational studies of epilepsy patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,5,24,25\">",
"     1,5,24,25",
"    </a>",
"    ]. In addition, prenatal exposure to these medications is associated with developmental delay [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/26\">",
"     26",
"    </a>",
"    ]. Specific drugs suggested as preconception and prenatal maintenance treatment and the teratogenic effects of valproate and carbamazepine are discussed separately. (See",
"    <a class=\"local\" href=\"#H51186202\">",
"     'Specific drugs'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=see_link&amp;anchor=H5#H5\">",
"     \"Risks associated with epilepsy and pregnancy\", section on 'Fetal and neonatal effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For bipolar patients who plan to become pregnant and decide to switch from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    to a less teratogenic drug, we suggest changing pharmacotherapy at least three to six months before patients try to conceive, to assess the effectiveness of the new medication. Valproate or carbamazepine are tapered and discontinued over 15 to 30 days; this approach appears to be associated with a lower risk of recurrence than a faster taper [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/2\">",
"     2",
"    </a>",
"    ]. The medication is tapered by the same amount for each dose decrease. As an example, valproate 2000 mg per day is decreased by 250 to 500 mg per day, every three to seven days. At the same time, the new medication is started and titrated up.",
"   </p>",
"   <p>",
"    Alternative medications may not work as well as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , and switching medications can precipitate a recurrence of bipolar mood symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/27\">",
"     27",
"    </a>",
"    ]. Thus, it is reasonable to maintain valproate or carbamazepine for patients with a history of poor outcomes using other medications, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    . Patients treated with valproate or carbamazepine during pregnancy should also receive high doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    (eg, 4 to 5 mg per day), although the efficacy of folate supplementation in reducing the risk of neural tube defects is not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/28\">",
"     28",
"    </a>",
"    ]. Managing pregnant patients who receive valproate or carbamazepine is discussed separately in the context of epilepsy, including the use of folic acid. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of epilepsy and pregnancy\", section on 'Management during pregnancy and delivery'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link&amp;anchor=H10#H10\">",
"     \"Folic acid for prevention of neural tube defects\", section on 'Anticonvulsant therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For bipolar patients who are maintained on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and unexpectedly become pregnant, we suggest switching medications. (See",
"    <a class=\"local\" href=\"#H14312316\">",
"     'Unplanned pregnancies'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7573636\">",
"    <span class=\"h2\">",
"     Monitoring patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar patients receiving preconception or prenatal maintenance pharmacotherapy should be regularly monitored for recurrence of manic and depressive symptoms as well as medication side effects. Particular attention is given to suicidal ideation and to psychotic symptoms. Stable patients can be seen every one to two months. For patients who remit from an acute mood episode and remain stable, monitoring can be tapered, with progressively longer intervals between assessments. As an example, a patient who is seen every two weeks at the time of remission can be seen every two weeks for one to three more visits, then every one to two months until parturition. More frequent visits should be scheduled for patients who develop symptoms or side effects; monitoring acutely ill patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4362?source=see_link&amp;anchor=H32030536#H32030536\">",
"     \"Bipolar disorder in pregnant women: Treatment of mania, hypomania, and mixed episodes\", section on 'Monitoring the patient'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55180124\">",
"    <span class=\"h2\">",
"     Adjunctive psychotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For bipolar patients who receive preconception or prenatal maintenance pharmacotherapy, we suggest adjunctive psychoeducation or cognitive-behavioral therapy (CBT), based upon randomized trials that excluded pregnant patients. Although no head-to-head trials have compared these psychotherapies, we generally choose psychoeducation because there are more data supporting its use, it is easier to administer than CBT and thus usually more available, and psychoeducation is generally an element of CBT. The evidence of efficacy for reducing recurrent mood episodes with other psychotherapies, such as family therapy and interpersonal and social rhythm therapy, is not as strong. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H20#H20\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Adjunctive psychotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H51186202\">",
"    <span class=\"h1\">",
"     SPECIFIC DRUGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized trials in bipolar patients who plan to or do become pregnant to guide preconception and prenatal maintenance pharmacotherapy; the benefits and risks of treatment are thus based upon randomized trials that excluded pregnant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/29-31\">",
"     29-31",
"    </a>",
"    ], as well as observational studies, birth registries, and clinical experience [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H328635\">",
"    <span class=\"h2\">",
"     First line",
"    </span>",
"    &nbsp;&mdash;&nbsp;For euthymic, bipolar patients who plan to or do become pregnant, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    as first line maintenance treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/5\">",
"     5",
"    </a>",
"    ], based upon randomized trials that excluded pregnant patients. There are more data supporting the efficacy of lamotrigine for the general maintenance treatment of bipolar disorder compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    . In addition, a prospective observational study of euthymic, pregnant bipolar patients found that relapse occurred in significantly fewer patients who continued lamotrigine (N = 10) than patients who stopped pharmacotherapy (N = 16) (30 versus 100 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/10\">",
"     10",
"    </a>",
"    ]. Further, the reproductive safety profile of lamotrigine is generally regarded as favorable [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/5,24,32\">",
"     5,24,32",
"    </a>",
"    ], and there is more experience using lamotrigine during pregnancy compared with quetiapine and risperidone. Although there are more data supporting the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    than lamotrigine, the reproductive safety of lamotrigine is generally regarded as comparable or superior to lithium.",
"   </p>",
"   <p>",
"    Evidence for the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    for delaying or preventing bipolar mood episodes is discussed separately, as are the reproductive safety profile of these drugs, and the dose schedule, side effect profile, and pharmacology of lamotrigine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H3#H3\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Pharmacotherapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link&amp;anchor=H5#H5\">",
"     \"Pharmacology of antiepileptic drugs\", section on 'Lamotrigine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H328643\">",
"    <span class=\"h2\">",
"     Resistant patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintenance treatment for bipolar disorder with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    is often not efficacious, based upon randomized trials (which excluded pregnant patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/29\">",
"     29",
"    </a>",
"    ]. For resistant bipolar patients who do not respond to or tolerate preconception or prenatal maintenance lamotrigine, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , based upon their efficacy and adverse effects in randomized trials that excluded pregnant patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/30,33\">",
"     30,33",
"    </a>",
"    ]. (Response is defined as psychopathology that is considerably less than full criteria for a mood episode, eg, no more than two moderately or three mildly intense symptoms.) No head-to-head trials have compared quetiapine and risperidone. The specific choice is thus based upon other factors, including past response to medications, side effect profiles, comorbid general medical conditions, patient preference, and cost.",
"   </p>",
"   <p>",
"    Although there are more data supporting the maintenance efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , study findings suggest that quetiapine and risperidone are not associated with an increased risk of major malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/34-37\">",
"     34-37",
"    </a>",
"    ], whereas lithium is generally regarded as teratogenic [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/20,23,38\">",
"     20,23,38",
"    </a>",
"    ]. In addition, the preference for treating pregnant bipolar patients with quetiapine or risperidone rather than lithium is consistent with practice guidelines from the United Kingdom National Institute for Health and Clinical Excellence [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/9,39\">",
"     9,39",
"    </a>",
"    ]. However, second generation antipsychotics may cause metabolic complications. (See",
"    <a class=\"local\" href=\"#H22544288\">",
"     'Metabolic complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    To switch drugs,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    is tapered and discontinued over one to two weeks while at the same time",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    is started and titrated up. We generally taper lamotrigine by the same amount for each dose decrease. As an example, lamotrigine 200 mg per day is decreased by 50 mg per day, every two to three days.",
"   </p>",
"   <p>",
"    For resistant bipolar patients who do not respond to preconception or prenatal maintenance treatment with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    , we suggest tapering and discontinuing the failed medication over one to two weeks while at the same time the other drug is started and titrated up. The failed medication is generally tapered by the same amount for each dose decrease. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    The efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    for the general maintenance treatment of bipolar disorder is discussed separately, as is the dose, side effect profile (",
"    <a class=\"graphic graphic_table graphicRef82533 \" href=\"UTD.htm?32/57/33694\">",
"     table 4",
"    </a>",
"    ), pharmacology, and reproductive safety profile. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link\">",
"     \"Bipolar disorder in adults: Maintenance treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=see_link\">",
"     \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link&amp;anchor=H1561513#H1561513\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\", section on 'Second-generation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22544288\">",
"    <span class=\"h3\">",
"     Metabolic complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Second-generation antipsychotics may cause hyperglycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/40\">",
"     40",
"    </a>",
"    ]. In pregnant women with diabetes, hyperglycemia is associated with increased risks of spontaneous abortion, congenital malformations, and macrosomia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/27/36281?source=see_link&amp;anchor=H3#H3\">",
"     \"Pregnancy risks in women with type 1 and type 2 diabetes mellitus\", section on 'Fetal and neonatal complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, second-generation antipsychotics may cause obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Obesity during pregnancy is associated with an increased risk of multiple obstetric complications, including gestational diabetes mellitus and pre-eclampsia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29882?source=see_link\">",
"     \"The impact of obesity on fertility and pregnancy\"",
"    </a>",
"    .) Although many clinicians use second-generation antipsychotics during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/42\">",
"     42",
"    </a>",
"    ], some authorities avoid them due to concerns about excessive weight gain and gestational diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/24,25,43\">",
"     24,25,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians using second-generation antipsychotics in pregnant patients should manage potential metabolic complications by monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/9,23,39\">",
"     9,23,39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weight gain",
"     </li>",
"     <li>",
"      Blood pressure",
"     </li>",
"     <li>",
"      Fasting serum glucose, cholesterol, and triglyceride concentrations. The normal reference range for cholesterol and triglycerides is generally higher in pregnant women compared with nonpregnant individuals (",
"      <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/7/14454?source=see_link\">",
"       \"Normal reference ranges for laboratory values in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients are assessed at baseline and every one to three months during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/17,23\">",
"     17,23",
"    </a>",
"    ]. In addition, a glucose tolerance test is performed every four months. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9210?source=see_link\">",
"     \"Screening and diagnosis of diabetes mellitus during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H328730\">",
"    <span class=\"h2\">",
"     Refractory patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon clinical experience, many bipolar patients do not respond to or tolerate sequential trials of preconception or prenatal maintenance",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    . For these refractory patients, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/11,17\">",
"     11,17",
"    </a>",
"    ]. (Response is defined as psychopathology that is considerably less than full criteria for a mood episode, eg, no more than two moderately or three mildly intense symptoms.) Evidence for the efficacy of lithium includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Randomized trials (that excluded pregnant patients) have demonstrated the benefit of maintenance treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      in bipolar disorder; these trials are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H5#H5\">",
"       \"Bipolar disorder in adults: Maintenance treatment\", section on 'Lithium'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A prospective observational study found that relapse occurred in significantly fewer pregnant bipolar patients who continued pharmacotherapy (N = 27, 85 percent received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      ) than patients who stopped pharmacotherapy (N = 62) (37 versus 86 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A prospective observational study found that relapse occurred in fewer pregnant bipolar patients who received maintenance pharmacotherapy (N = 31, 97 percent received",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      ) than patients who did not (N = 10) (19 versus 40 percent; statistical significance not tested) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    is generally regarded as teratogenic due to increased risks of cardiac defects (eg, Ebstein&rsquo;s anomaly) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/20,23,38\">",
"     20,23,38",
"    </a>",
"    ], many authorities consider the absolute risk small [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,5,24,25,44\">",
"     1,5,24,25,44",
"    </a>",
"    ]. For pregnant patients using lithium, we suggest prenatal screening for anomalies with high-resolution ultrasonography at 16 to 18 weeks gestation, and depending upon the results, fetal echocardiography, which can aid decisions about pregnancy termination, referral for delivery at a hospital with the appropriate level of neonatal care, and postnatal interventions for congenital malformations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,8,25\">",
"     1,8,25",
"    </a>",
"    ]. The teratogenic effects of lithium are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link&amp;anchor=H1561534#H1561534\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For pregnant patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , we suggest using the lowest amount necessary to achieve a therapeutic serum concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/20\">",
"     20",
"    </a>",
"    ]. The total daily dose is often given in two to three divided doses (rather than a single daily dose) using controlled release preparations, to avoid high peak serum levels [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/15,45,46\">",
"     15,45,46",
"    </a>",
"    ]; however, it is not known whether this reduces the risk of teratogenic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/45\">",
"     45",
"    </a>",
"    ]. Serum lithium concentrations are checked every two to four weeks during pregnancy, until 36 weeks gestation, at which point levels should be checked weekly [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/7,21,23\">",
"     7,21,23",
"    </a>",
"    ]. The dose schedule for lithium, use of serum concentrations to establish the proper dose, and lithium toxicity are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43065?source=see_link\">",
"     \"Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional laboratory monitoring of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    includes thyroid and renal function tests that are checked at baseline and repeated every three months [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/23\">",
"     23",
"    </a>",
"    ]. Normal reference ranges for laboratory tests often differ for gravid and nongravid patients (",
"    <a class=\"graphic graphic_table graphicRef81137 \" href=\"UTD.htm?37/33/38424\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/7/14454?source=see_link\">",
"     \"Normal reference ranges for laboratory values in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    concentrations generally decrease during pregnancy and the doses required to effectively prevent bipolar mood episodes thus increase [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,19\">",
"     1,19",
"    </a>",
"    ]. These changes are a consequence of increases in maternal glomerular filtration rate and extracellular fluid volume and their impact upon pharmacokinetics. As an example, renal excretion of lithium may increase 30 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/20,21,46\">",
"     20,21,46",
"    </a>",
"    ]. During the second and third trimesters, twice the prepregnancy dose of lithium may be required to achieve therapeutic serum concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/45\">",
"     45",
"    </a>",
"    ]. In addition, serum lithium concentrations can be altered by concomitant medications and other clinical factors (eg, diarrhea). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43065?source=see_link&amp;anchor=H182696749#H182696749\">",
"     \"Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects\", section on 'Prescribing lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Frequent urination, thirst, weight gain, and nausea are common during pregnancy and can be exacerbated by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    . Side effects of lithium are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43065?source=see_link&amp;anchor=H182696807#H182696807\">",
"     \"Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects\", section on 'Lithium side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For pregnant patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , delivery should occur in facilities with the ability to resuscitate neonates, given the risks of postnatal complications [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/23\">",
"     23",
"    </a>",
"    ]. Postnatal toxicity and withdrawal secondary to lithium are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link&amp;anchor=H1561534#H1561534\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest withholding",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    for one to two days before a scheduled delivery or at the onset of labor, consistent with the practice of many perinatal psychiatrists [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/7,21,47\">",
"     7,21,47",
"    </a>",
"    ]. Although a brief reduction in serum lithium concentrations may possibly precipitate a postpartum relapse, the risk seems small. In a prospective observational study of nine pregnant bipolar patients treated with lithium in the third trimester, lithium was withheld for one to two days before a scheduled delivery or at the onset of labor; maternal serum concentrations decreased from a mean of 0.8",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    to 0.5",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    (0.5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    and none of the patients became symptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For pregnant patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , adequate hydration must be maintained throughout labor, especially if the serum level drawn at the time of delivery is high. During labor and delivery, vascular volume can decrease through loss of blood as well as diaphoresis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/19\">",
"     19",
"    </a>",
"    ]. Intravenous fluids are typically used to prevent dehydration and lithium toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/7,17\">",
"     7,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After delivery,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    is resumed when patients are medically stable (provided breastfeeding is not planned) at doses lower than those used during the third trimester, because maternal glomerular filtration rates rapidly decrease to pregravid levels [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Patients treated with lithium prior to conception are restarted on the prepregnancy dose. Patients not treated with lithium prior to conception are usually started at a dose of 600 to 900 mg per day, which is then increased by 300 to 600 mg every one to five days based upon response, tolerability, and body mass index. Serum concentrations are measured 24 hours after delivery and every three to five days until they stabilize at a therapeutic level. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43065?source=see_link&amp;anchor=H182696765#H182696765\">",
"     \"Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects\", section on 'Lithium dose and serum concentrations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The newborn should be monitored for symptoms of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    toxicity for up to 10 days after delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/20,48\">",
"     20,48",
"    </a>",
"    ], even if the maternal serum lithium concentration at delivery is within normal limits. Signs of neonatal toxicity at the time of delivery should prompt a cord serum level [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/23\">",
"     23",
"    </a>",
"    ] and a neonatal electrocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/20,48\">",
"     20,48",
"    </a>",
"    ]. Neonatal lithium toxicity and withdrawal are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=see_link&amp;anchor=H1561534#H1561534\">",
"     \"Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy\", section on 'Lithium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14312316\">",
"    <span class=\"h1\">",
"     UNPLANNED PREGNANCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unintended pregnancies in bipolar patients are common and may precipitate mood episodes. Two prospective observational studies of pregnant bipolar patients (N = 89 and 26) found that the pregnancy was not planned in 34 and 58 percent, and that unplanned pregnancy was associated with recurrent prenatal mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/2,10\">",
"     2,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For euthymic bipolar patients who unintentionally become pregnant during maintenance treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    , a second-generation antipsychotic, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    , we suggest continuing the same drug [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For bipolar patients who are maintained on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    and unexpectedly become pregnant, we suggest switching medications. We typically titrate up the new drug as rapidly as tolerated, and then taper and discontinue the antiepileptic over the course of a few days. The antiepileptic is decreased the same amount for each dose reduction. As an example, valproate 1500 mg per day is decreased by 500 mg every one to two days. The choice of a new drug is discussed elsewhere in this topic, as is management of patients who decline switching medications. (See",
"    <a class=\"local\" href=\"#H51186202\">",
"     'Specific drugs'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H259027145\">",
"     'Switching from valproate or carbamazepine to less teratogenic drugs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Bipolar patients who unexpectedly become pregnant may decide to discontinue maintenance pharmacotherapy. However, stopping medications (particularly over a period of less than two weeks) may increase the risk of recurrent mood episodes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40329?source=see_link&amp;anchor=H317273#H317273\">",
"     \"Bipolar disorder in women: Contraception and preconception assessment and counseling\", section on 'Relapse after discontinuing pharmacotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Determining the gestational age will inform the decision to use maintenance pharmacotherapy in bipolar patients with unplanned pregnancies. The period of greatest risk for the teratogenic effects of medications is between the third and eighth week of gestation (weeks of gestation are counted from the first day of the last menstrual period) (",
"    <a class=\"graphic graphic_figure graphicRef65816 \" href=\"UTD.htm?32/30/33261\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef56642 \" href=\"UTD.htm?22/46/23272\">",
"     figure 2",
"    </a>",
"    ). Many unplanned pregnancies are discovered after this period of greatest risk has passed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/1,49\">",
"     1,49",
"    </a>",
"    ]; thus, discontinuing or switching treatment at this point often puts the mother at risk for relapse of a mood episode and provides minimal benefit to the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?2/51/2874/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1340392\">",
"    <span class=\"h1\">",
"     FOLIC ACID SUPPLEMENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     Folic acid",
"    </a>",
"    is recommended for every woman planning to conceive a child and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link&amp;anchor=H18#H18\">",
"     \"Nutrition in pregnancy\", section on 'Folic acid'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"     \"Folic acid for prevention of neural tube defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of epilepsy and pregnancy\", section on 'Folic acid supplementation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (See",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/5/4178?source=see_link\">",
"       \"Patient information: Bipolar disorder (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/55/39796?source=see_link\">",
"       \"Patient information: Bipolar disorder (manic depression) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These educational materials can be used as part of psychoeducational psychotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H21#H21\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Psychoeducation'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The National Institute of Mental Health also has educational material explaining the symptoms, course of illness, and treatment of bipolar disorder in a booklet entitled \"Bipolar Disorder,\" which is available online at the website",
"    <a class=\"external\" href=\"file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml\">",
"     file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml",
"    </a>",
"    or through a toll-free number, 866-615-6464. The web site also provides references, summaries of study results in language intended for the lay public, and information about clinical trials currently recruiting patients.",
"   </p>",
"   <p>",
"    More comprehensive information is provided in many books written for patients and family members, including The Bipolar Disorder Survival Guide: What You and Your Family Need to Know, written by David J. Miklowitz, PhD (published by The Guilford Press, 2002); An Unquiet Mind: A Memoir of Moods and Madness, written by Kay Jamison, PhD (published by Random House, 1995); and Treatment of Bipolar Illness: A Casebook for Clinicians and Patients, by RM Post, MD, and GS Leverich, LCSW (published by Norton Press, 2008).",
"   </p>",
"   <p>",
"    The Depression and Bipolar Support Alliance (",
"    <a class=\"external\" href=\"file://www.dbsalliance.org/\">",
"     file://www.dbsalliance.org",
"    </a>",
"    or 800-826-3632) is a national organization that educates members about bipolar disorder and how to cope with it. Other functions include increasing public awareness of the illness and advocating for more research and services. The organization is administered and maintained by patients and family members, and has local chapters.",
"   </p>",
"   <p>",
"    The National Alliance on Mental Illness (",
"    <a class=\"external\" href=\"file://www.nami.org/\">",
"     file://www.nami.org",
"    </a>",
"    or 800-950-6264) is a similarly structured organization devoted to education, support, and advocacy for patients with any mental illness. Bipolar disorder is one of their priorities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1340835\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bipolar disorder is a mood disorder that is characterized by episodes of mania (",
"      <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"       table 1",
"      </a>",
"      ), hypomania (",
"      <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"       table 2",
"      </a>",
"      ), and major depression (",
"      <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"       table 3",
"      </a>",
"      ), as well as mixed episodes (major depression concurrent with mania or hypomania). (See",
"      <a class=\"local\" href=\"#H581793\">",
"       'Definition of bipolar disorder'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H4#H4\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Clinical manifestations and diagnostic criteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bipolar disorder is a highly recurrent illness. For bipolar patients who plan to or do become pregnant, we suggest maintenance pharmacotherapy rather than no treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, for patients with a mild lifetime course of illness, it is reasonable to try to avoid pharmacotherapy during pregnancy. (See",
"      <a class=\"local\" href=\"#H259024962\">",
"       'General principles'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25638?source=see_link\">",
"       \"Bipolar disorder in women: Indications for preconception and prenatal maintenance pharmacotherapy\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H259025003\">",
"       'Risks of avoiding pharmacotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In prescribing preconception or prenatal maintenance pharmacotherapy for bipolar patients, clinicians should attempt to use drugs with fewer known teratogenic effects, monotherapy, and doses at the low end of the therapeutic range. Following the first trimester, the risk of teratogenesis decreases and it is safer to prescribe drug combinations and higher doses. (See",
"      <a class=\"local\" href=\"#H259024962\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"       Valproate",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      are generally regarded as teratogens. For stable bipolar patients who plan to or do become pregnant and are currently treated with valproate and carbamazepine, we suggest switching treatment to a less teratogenic drug rather than maintaining valproate or carbamazepine (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, it is reasonable to maintain valproate or carbamazepine for patients with a history of poor outcomes using other medications. (See",
"      <a class=\"local\" href=\"#H259027145\">",
"       'Switching from valproate or carbamazepine to less teratogenic drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For bipolar patients who plan to or do become pregnant, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      as first line maintenance treatment rather than other medications (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H328635\">",
"       'First line'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who are unresponsive to or intolerant of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      , we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      rather than other medications (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H328643\">",
"       'Resistant patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For refractory patients who do not respond to sequential maintenance treatment trials with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"       lamotrigine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      is a reasonable option. Although lithium is generally regarded as teratogenic due to increased risks of cardiac defects, the absolute risk is considered low. (See",
"      <a class=\"local\" href=\"#H328730\">",
"       'Refractory patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For bipolar patients with unplanned pregnancies, determining the gestational age will inform the decision to use maintenance pharmacotherapy. The period of greatest risk for the teratogenic effects of medications is between the third and eighth week of gestation (",
"      <a class=\"graphic graphic_figure graphicRef65816 \" href=\"UTD.htm?32/30/33261\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef56642 \" href=\"UTD.htm?22/46/23272\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14312316\">",
"       'Unplanned pregnancies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Every woman planning to conceive a child should receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=see_link&amp;anchor=H18#H18\">",
"       \"Nutrition in pregnancy\", section on 'Folic acid'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"       \"Folic acid for prevention of neural tube defects\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=see_link&amp;anchor=H4#H4\">",
"       \"Management of epilepsy and pregnancy\", section on 'Folic acid supplementation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/1\">",
"      Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/2\">",
"      Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/3\">",
"      Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64:543.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/5\">",
"      ACOG Committee on Practice Bulletins--Obstetrics. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008; 111:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/6\">",
"      Jones I, Craddock N. Bipolar disorder and childbirth: the importance of recognising risk. Br J Psychiatry 2005; 186:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/7\">",
"      Galbally M, Snellen M, Lewis AJ. A review of the use of psychotropic medication in pregnancy. Curr Opin Obstet Gynecol 2011; 23:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/8\">",
"      Burt VK, Bernstein C, Rosenstein WS, Altshuler LL. Bipolar disorder and pregnancy: maintaining psychiatric stability in the real world of obstetric and psychiatric complications. Am J Psychiatry 2010; 167:892.",
"     </a>",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practice Guideline Number 38 file://www.nice.org.uk/ (Accessed on December 30, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/10\">",
"      Newport DJ, Stowe ZN, Viguera AC, et al. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord 2008; 10:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/11\">",
"      Cohen LS. Treatment of bipolar disorder during pregnancy. J Clin Psychiatry 2007; 68 Suppl 9:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/12\">",
"      Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord 2004; 6:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/13\">",
"      Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 2002; 47:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/14\">",
"      Gentile S. Bipolar disorder in pregnancy: to treat or not to treat? BMJ 2012; 345:e7367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/15\">",
"      Bergink V, Bouvy PF, Vervoort JS, et al. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry 2012; 169:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/16\">",
"      Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 2010; 36:518.",
"     </a>",
"    </li>",
"    <li>",
"     Burt VK, Stein K. Treatment of women. In: The American Psychiatric Publishing Textbook of Psychiatry, Fifth Edition, Hales RE, Yodofsky SC, Gabbard GO.  (Eds), American Psychiatric Publishing, Inc., Washington, DC 2008. p.1489.",
"    </li>",
"    <li>",
"     Frey BN, Macritchie KA, Soares CN, Steiner M. Bipolar disorder in women. In: Bipolar Disorder: Clinical and Neurobiological Foundations, Yatham LN, Maj M.  (Eds), Wiley-Blackwell, West Sussex 2010. p.463.",
"    </li>",
"    <li>",
"     Newport DJ, Fernandez SV, Juric S, Stowe ZN. Psychopharmacology during pregnancy and lactation. In: The American Psychiatric Publishing Textbook of Psychopharmacology, Fourth Edition, Schatzberg AF, Nemeroff CB.  (Eds), American Psychiatric Publishing, Inc., Washington, D.C. 2009. p.1373.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/20\">",
"      Jain AE, Lacy T. Psychotropic drugs in pregnancy and lactation. J Psychiatr Pract 2005; 11:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/21\">",
"      Deligiannidis KM. Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. J Clin Psychiatry 2010; 71:649.",
"     </a>",
"    </li>",
"    <li>",
"     Goodwin FK, Jamison KR. Maintenance medical treatment. In: Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edition, Oxford University Press, New York 2007. p.797.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/23\">",
"      Galbally M, Snellen M, Walker S, Permezel M. Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care. Aust N Z J Psychiatry 2010; 44:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/24\">",
"      Gentile S. Drug treatment for mood disorders in pregnancy. Curr Opin Psychiatry 2011; 24:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/25\">",
"      Cohen LS, Wang B, Nonacs R, et al. Treatment of mood disorders during pregnancy and postpartum. Psychiatr Clin North Am 2010; 33:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/26\">",
"      Cummings C, Stewart M, Stevenson M, et al. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 2011; 96:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/27\">",
"      Goodwin GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009; 23:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/28\">",
"      Jentink J, Bakker MK, Nijenhuis CM, et al. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Pharmacoepidemiol Drug Saf 2010; 19:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/29\">",
"      Smith LA, Cornelius V, Warnock A, et al. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disord 2007; 9:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/30\">",
"      Weisler RH, Nolen WA, Neijber A, et al. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study). J Clin Psychiatry 2011; 72:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/31\">",
"      Cipriani A, Rendell JM, Geddes J. Olanzapine in long-term treatment for bipolar disorder. Cochrane Database Syst Rev 2009; :CD004367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/32\">",
"      Marangell LB. Current issues: women and bipolar disorder. Dialogues Clin Neurosci 2008; 10:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/33\">",
"      Quiroz JA, Yatham LN, Palumbo JM, et al. Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Biol Psychiatry 2010; 68:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/34\">",
"      Einarson A, Boskovic R. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 2009; 15:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/35\">",
"      McKenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 2005; 66:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/36\">",
"      Newport DJ, Calamaras MR, DeVane CL, et al. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 2007; 164:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/37\">",
"      Coppola D, Russo LJ, Kwarta RF Jr, et al. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 2007; 30:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/38\">",
"      Kloos AL, Dubin-Rhodin A, Sackett JC, et al. The impact of mood disorders and their treatment on the pregnant woman, the fetus, and the infant. Curr Psychiatry Rep 2010; 12:96.",
"     </a>",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. NICE clinical guideline 45. Antenatal and postnatal mental health: Clinical management and service guidance. April 2007 file://www.nice.org.uk/CG045 (Accessed on January 01, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/40\">",
"      De Hert M, Detraux J, van Winkel R, et al. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 2012; 8:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/41\">",
"      Choong E, Bondolfi G, Etter M, et al. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population. J Psychiatr Res 2012; 46:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/42\">",
"      Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 2011; 117:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/43\">",
"      Bod&eacute;n R, Lundgren M, Brandt L, et al. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects. Arch Gen Psychiatry 2012; 69:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/44\">",
"      Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153:592.",
"     </a>",
"    </li>",
"    <li>",
"     Stewart DE, Vigod SN, Stotland NL. Obstetrics and gynecology. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL.  (Ed), American Psychiatric Publishing, Inc, Washington, DC 2011. p.797.",
"    </li>",
"    <li>",
"     Janicak PG, Marder SR, Pavuluri MN. Principles and Practice of Psychopharmacotherapy, Fifth Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2011. p.367.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/47\">",
"      Newport DJ, Viguera AC, Beach AJ, et al. Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 2005; 162:2162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/48\">",
"      Menon SJ. Psychotropic medication during pregnancy and lactation. Arch Gynecol Obstet 2008; 277:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/51/2874/abstract/49\">",
"      Freeman MP. Bipolar disorder and pregnancy: risks revealed. Am J Psychiatry 2007; 164:1771.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16971 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-EA0AF42627-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2874=[""].join("\n");
var outline_f2_51_2874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1340835\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H581521\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H581793\">",
"      DEFINITION OF BIPOLAR DISORDER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4469121\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H259024962\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1046366\">",
"      Risk of adverse pregnancy and birth outcomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H55179445\">",
"      Teratogenic and postnatal risks of pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H259025003\">",
"      Risks of avoiding pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H259027145\">",
"      Switching from valproate or carbamazepine to less teratogenic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7573636\">",
"      Monitoring patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H55180124\">",
"      Adjunctive psychotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H51186202\">",
"      SPECIFIC DRUGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H328635\">",
"      First line",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H328643\">",
"      Resistant patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22544288\">",
"      - Metabolic complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H328730\">",
"      Refractory patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14312316\">",
"      UNPLANNED PREGNANCIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1340392\">",
"      FOLIC ACID SUPPLEMENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1340835\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/16971\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/16971|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/30/33261\" title=\"figure 1\">",
"      Risk wk for fetal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/46/23272\" title=\"figure 2\">",
"      The developing fetus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/16971|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/53/3932\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for mania",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/39/23164\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for hypomania",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17756\" title=\"table 3\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/57/33694\" title=\"table 4\">",
"      Adverse effects for antipsychotic meds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/33/38424\" title=\"table 5\">",
"      Normal reference ranges in pregnant women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43065?source=related_link\">",
"      Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=related_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=related_link\">",
"      Bipolar disorder in adults: Maintenance treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/8/38026?source=related_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11226?source=related_link\">",
"      Bipolar disorder in adults: Teratogenic and postnatal risks of pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/16/4362?source=related_link\">",
"      Bipolar disorder in pregnant women: Treatment of mania, hypomania, and mixed episodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40329?source=related_link\">",
"      Bipolar disorder in women: Contraception and preconception assessment and counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/2/25638?source=related_link\">",
"      Bipolar disorder in women: Indications for preconception and prenatal maintenance pharmacotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/16/15625?source=related_link\">",
"      Management of epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/7/14454?source=related_link\">",
"      Normal reference ranges for laboratory values in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/44/28362?source=related_link\">",
"      Nutrition in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/5/4178?source=related_link\">",
"      Patient information: Bipolar disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/55/39796?source=related_link\">",
"      Patient information: Bipolar disorder (manic depression) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/27/36281?source=related_link\">",
"      Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=related_link\">",
"      Risks associated with epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9210?source=related_link\">",
"      Screening and diagnosis of diabetes mellitus during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15015?source=related_link\">",
"      Surrogate pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/11/29882?source=related_link\">",
"      The impact of obesity on fertility and pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_51_2875="Classification of G proteins";
var content_f2_51_2875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52173&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of G protein-coupled receptors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Catecholamines, acetylcholine, serotonin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrin/CCK, neuropeptide Y, substance P",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class II",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Secretin, glucagon, vasoactive intestinal polypeptide, glucagon-like peptide 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glutamate-metabotrophic receptors, calcium receptors",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2875=[""].join("\n");
var outline_f2_51_2875=null;
var title_f2_51_2876="Neurologic predictors of prognosis after cardiac arrest";
var content_f2_51_2876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79948&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Significance of physical findings in coma following cardiac arrest",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"2\" rowspan=\"1\">",
"        Patients with virtually no chance of regaining independence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial examination",
"       </td>",
"       <td>",
"        No pupillary light reflex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One day",
"       </td>",
"       <td>",
"        Motor response no better than flexor and spontaneous eye movements neither orienting nor roving conjugate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Three days",
"       </td>",
"       <td>",
"        Motor response no better than flexor, no spontaneous eye opening",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One week",
"       </td>",
"       <td>",
"        Motor response not obeying commands and spontaneous eye movements neither orienting nor roving conjugate.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two weeks",
"       </td>",
"       <td>",
"        Oculocephalic response not normal, not obeying commands, no",
"spontaneous eye opening, eye opening not improved at least 2 grades",
"from initial examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"2\" rowspan=\"1\">",
"        Patients with best chance of regaining independence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Initial examination",
"       </td>",
"       <td>",
"        Pupillary light reflexes present and motor response flexor or extensor. Spontaneous eye movements roving conjugate or orienting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One day",
"       </td>",
"       <td>",
"        Motor response withdrawal or better and eye opening improved at least 2 grades",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Three day",
"       </td>",
"       <td>",
"        Motor response withdrawal or better and spontaneous eye movements normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One week",
"       </td>",
"       <td>",
"        Motor response obeying commands",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two weeks",
"       </td>",
"       <td>",
"        Normal oculocephalic response",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2876=[""].join("\n");
var outline_f2_51_2876=null;
var title_f2_51_2877="Saw tooth pattern in OSA";
var content_f2_51_2877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flow-volume loop in obstructive sleep apnea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 270px; height: 262px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow-volume loop in obstructive sleep apnea showing a saw-tooth pattern. The intersections with the x-axis are at total lung capacity (TLC) on the left and residual volume (RV) on the right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2877=[""].join("\n");
var outline_f2_51_2877=null;
var title_f2_51_2878="Sleep efficiency insomnia";
var content_f2_51_2878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F58496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F58496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sleep efficiency in insomniacs during three consecutive parts (I, II, and III) of the night, following placebo or melatonin (0.3 mg) treatment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 354px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Zhdanova IV, Wurtman RJ, Regan MM,&nbsp;et al. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab 2001; 86:4727. file://jcem.endojournals.org/.&nbsp;Copyright &copy; 2001 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2878=[""].join("\n");
var outline_f2_51_2878=null;
var title_f2_51_2879="Mallet finger photo";
var content_f2_51_2879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77830&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mallet finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rebecca Bassett, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_51_2879=[""].join("\n");
var outline_f2_51_2879=null;
